BPI-7711

· Beta Pharma Shanghai

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BPI-7711, covering 2022-05-16 to 2022-05-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive [Phase 2]

See pricing